Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Director departure

Passage BIO, Inc. (PASG) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2023 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Passage BIO, Inc.
Txns: Bought 617,382 shares @ $0.84, valued at $518.6k
Bought 575,195 shares @ $0.84, valued at $483.2k
05/26/2023 4 Woiwode Thomas (10% Owner) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 24,000 options to buy @ $1, valued at $24k
05/26/2023 4 Porter Derrell (Director) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 24,000 options to buy @ $1, valued at $24k
05/26/2023 4 Kapadia Sandip (Director) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 24,000 options to buy @ $1, valued at $24k
05/26/2023 4 Kamarck Michael E. (Director) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 21,567 options to buy @ $1, valued at $21.6k
05/26/2023 4 Islam Saqib (Director) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 24,000 options to buy @ $1, valued at $24k
05/26/2023 4 GOWEN MAXINE (Director) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 24,000 options to buy @ $1, valued at $24k
05/26/2023 4 Countouriotis Athena (Director) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 24,000 options to buy @ $1, valued at $24k
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2023 4 Chou William (President and CEO) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 608,615 options to buy @ $1.08, valued at $657.3k
04/05/2023 4 King Simona (CFO) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 140,000 options to buy @ $1.08, valued at $151.2k
04/05/2023 4 Forman Mark S (Chief Medical Officer) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 175,000 options to buy @ $1.08, valued at $189k
04/05/2023 4 Cale Edgar B. (GC & Corporate Secretary) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 175,000 options to buy @ $1.08, valued at $189k
04/05/2023 4 Fotopoulos Alexandros (Chief Technical Officer) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 175,000 options to buy @ $1.08, valued at $189k
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2022 4 Chou William (CEO) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 885,000 options to buy @ $1.32, valued at $1.2M
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2022 4 Forman Mark S (Chief Medical Officer) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 136,000 options to buy @ $2.29, valued at $311.4k
06/15/2022 4 Cale Edgar B. (Interim CEO, GC & Corp. Sec.) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 106,000 options to buy @ $2.29, valued at $242.7k
06/15/2022 4 Fotopoulos Alexandros (Chief Technical Officer) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 200,000 options to buy @ $2.29, valued at $458k
06/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/01/2022 4 Cale Edgar B. (Interim CEO, GC & Corp. Sec.) has filed a Form 4 on Passage BIO, Inc.
Txns: Granted 100,000 options to buy @ $1.8, valued at $180k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy